Friedrich Scheiflinger

4.2k total citations
100 papers, 3.2k citations indexed

About

Friedrich Scheiflinger is a scholar working on Hematology, Immunology and Genetics. According to data from OpenAlex, Friedrich Scheiflinger has authored 100 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Hematology, 29 papers in Immunology and 22 papers in Genetics. Recurrent topics in Friedrich Scheiflinger's work include Hemophilia Treatment and Research (44 papers), Platelet Disorders and Treatments (33 papers) and Blood Coagulation and Thrombosis Mechanisms (30 papers). Friedrich Scheiflinger is often cited by papers focused on Hemophilia Treatment and Research (44 papers), Platelet Disorders and Treatments (33 papers) and Blood Coagulation and Thrombosis Mechanisms (30 papers). Friedrich Scheiflinger collaborates with scholars based in Austria, United States and Netherlands. Friedrich Scheiflinger's co-authors include Friedrich Dorner, Falko G. Falkner, Michael Dockal, G. Antoine, Barbara Plaimauer, Denisa D. Wagner, Anil K. Chauhan, Manfred Rieger, Paul Knöbl and Johanna A. Kremer Hovinga and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Friedrich Scheiflinger

95 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Friedrich Scheiflinger Austria 28 1.5k 1.4k 609 589 521 100 3.2k
Rudolf A. Manz Germany 36 791 0.5× 3.7k 2.6× 462 0.8× 1.1k 1.9× 525 1.0× 77 6.0k
Thomas F. Lint United States 30 476 0.3× 1.4k 1.0× 373 0.6× 469 0.8× 265 0.5× 68 2.3k
Matthias Ballmaier Germany 34 1.1k 0.8× 1.7k 1.2× 184 0.3× 898 1.5× 447 0.9× 83 3.8k
Robert Korngold United States 41 2.4k 1.7× 3.9k 2.8× 323 0.5× 978 1.7× 272 0.5× 153 5.5k
D T Fearon United States 18 898 0.6× 2.2k 1.5× 250 0.4× 588 1.0× 342 0.7× 29 3.2k
HD Ochs United States 30 916 0.6× 2.0k 1.4× 529 0.9× 875 1.5× 273 0.5× 63 3.9k
József Dobó Hungary 31 855 0.6× 1.7k 1.2× 201 0.3× 511 0.9× 537 1.0× 78 2.6k
Eric Wattel France 34 2.0k 1.4× 1.4k 1.0× 214 0.4× 1.4k 2.4× 1.2k 2.2× 132 4.5k
Soo Young Yang United States 31 748 0.5× 4.4k 3.1× 348 0.6× 877 1.5× 139 0.3× 90 5.4k
Cecilia Sgadari Italy 29 252 0.2× 1.6k 1.1× 562 0.9× 1.3k 2.2× 195 0.4× 68 4.2k

Countries citing papers authored by Friedrich Scheiflinger

Since Specialization
Citations

This map shows the geographic impact of Friedrich Scheiflinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Friedrich Scheiflinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Friedrich Scheiflinger more than expected).

Fields of papers citing papers by Friedrich Scheiflinger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Friedrich Scheiflinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Friedrich Scheiflinger. The network helps show where Friedrich Scheiflinger may publish in the future.

Co-authorship network of co-authors of Friedrich Scheiflinger

This figure shows the co-authorship network connecting the top 25 collaborators of Friedrich Scheiflinger. A scholar is included among the top collaborators of Friedrich Scheiflinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Friedrich Scheiflinger. Friedrich Scheiflinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hartmann, Rudolf, et al.. (2020). A bispecific antibody demonstrates limited measurability in routine coagulation assays. Blood Coagulation & Fibrinolysis. 31(6). 353–365. 4 indexed citations
2.
Haider, N., et al.. (2019). How Full-Length FVIII Benefits from Its Heterogeneity – Insights into the Role of the B-Domain. Pharmaceutical Research. 36(5). 77–77. 4 indexed citations
3.
Fu, Hongxia, Yan Jiang, Darren Yang, et al.. (2017). Flow-induced elongation of von Willebrand factor precedes tension-dependent activation. Nature Communications. 8(1). 324–324. 150 indexed citations
4.
Annoni, Andrea, Mauro Biffi, Fabio Russo, et al.. (2017). Genome editing for scalable production of alloantigen‐free lentiviral vectors for in vivo gene therapy. EMBO Molecular Medicine. 9(11). 1558–1573. 44 indexed citations
5.
Hartmann, Rudolf, et al.. (2017). A Bispecific Antibody Lacks Measurability in Routine Coagulation Assays and Comparability to Factor VIII. Blood. 130. 1080–1080. 1 indexed citations
6.
Bonazza, Klaus, Hanspeter Rottensteiner, Gerald Schrenk, et al.. (2015). Ca2+ concentration-dependent conformational change of FVIII B-domain observed by atomic force microscopy. Analytical and Bioanalytical Chemistry. 407(20). 6051–6056. 9 indexed citations
7.
Turecek, Peter L., Srilatha Tangada, Herbert Gritsch, et al.. (2015). Nonacog gamma, a novel recombinant factor IX with low factor IXa content for treatment and prophylaxis of bleeding episodes. Expert Review of Clinical Pharmacology. 8(2). 163–177. 6 indexed citations
8.
Freissmuth, Michael, Dirk Völkel, Michael Thiele, et al.. (2013). Human Anti-Macrophage Migration Inhibitory Factor Antibodies Inhibit Growth of Human Prostate Cancer Cells In Vitro and In Vivo. Molecular Cancer Therapeutics. 12(7). 1223–1234. 59 indexed citations
9.
Schuster, Maria, Markus Weiller, Gerhard Antoine, et al.. (2013). Development of a Transgenic Mouse Model with Immune Tolerance for Human Coagulation Factor VIIa. Pharmaceutical Research. 30(11). 2855–2867. 2 indexed citations
10.
Dockal, Michael, Rudolf Hartmann, Markus Fries, et al.. (2013). Small Peptides Blocking Inhibition of Factor Xa and Tissue Factor-Factor VIIa by Tissue Factor Pathway Inhibitor (TFPI). Journal of Biological Chemistry. 289(3). 1732–1741. 38 indexed citations
11.
Ferrari, Silvia, Geert C. Mudde, Michael Rieger, et al.. (2009). IgG subclass distribution of anti‐ADAMTS13 antibodies in patients with acquired thrombotic thrombocytopenic purpura. Journal of Thrombosis and Haemostasis. 7(10). 1703–1710. 129 indexed citations
12.
Chauhan, Anil K., Janka Kisucka, Alexander Brill, et al.. (2008). ADAMTS13: a new link between thrombosis and inflammation. The Journal of Experimental Medicine. 205(9). 2065–2074. 168 indexed citations
13.
Zimmermann, Klaus F., et al.. (2004). Native Versus Recombinant High-Mobility Group B1 Proteins: Functional Activity In Vitro. Inflammation. 28(4). 221–229. 51 indexed citations
14.
Plaimauer, Barbara & Friedrich Scheiflinger. (2004). Expression and characterization of recombinant human ADAMTS-13. Seminars in Hematology. 41(1). 24–33. 22 indexed citations
15.
Völkel, Dirk, Klaus F. Zimmermann, Andreas Breitwieser, et al.. (2003). Immunochemical detection of prion protein on dipsticks prepared with crystalline bacterial cell‐surface layers. Transfusion. 43(12). 1677–1682. 11 indexed citations
16.
Patterson, John B., Friedrich Scheiflinger, Marianne Manchester, Tilahun Yilma, & Michael B. A. Oldstone. (1999). Structural and Functional Studies of the Measles Virus Hemagglutinin: Identification of a Novel Site Required for CD46 Interaction. Virology. 256(1). 142–151. 35 indexed citations
17.
Antoine, G., Friedrich Scheiflinger, Friedrich Dorner, & Falko G. Falkner. (1998). The Complete Genomic Sequence of the Modified Vaccinia Ankara Strain: Comparison with Other Orthopoxviruses. Virology. 244(2). 365–396. 421 indexed citations
18.
Scheiflinger, Friedrich, Friedrich Dorner, & Falko G. Falkner. (1998). Transient marker stabilisation: a general procedure to construct marker-free recombinant vaccinia virus. Archives of Virology. 143(3). 467–474. 18 indexed citations
19.
Tishon, Antoinette, Marianne Manchester, Friedrich Scheiflinger, & Michael B. A. Oldstone. (1996). A model of measles virus–induced immunosuppression: Enhanced susceptibility of neonatal human PBLs. Nature Medicine. 2(11). 1250–1254. 24 indexed citations
20.
Scheiflinger, Friedrich, Friedrich Dorner, & Falko G. Falkner. (1992). Construction of chimeric vaccinia viruses by molecular cloning and packaging.. Proceedings of the National Academy of Sciences. 89(21). 9977–9981. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rudolf A. Manz Breakdown of academic impact, for papers by Thomas F. Lint Breakdown of academic impact, for papers by Matthias Ballmaier Breakdown of academic impact, for papers by Robert Korngold Breakdown of academic impact, for papers by D T Fearon Breakdown of academic impact, for papers by HD Ochs Breakdown of academic impact, for papers by József Dobó Breakdown of academic impact, for papers by Eric Wattel Breakdown of academic impact, for papers by Soo Young Yang Breakdown of academic impact, for papers by Cecilia Sgadari
Rankless by CCL
2026